[Federal Register Volume 84, Number 165 (Monday, August 26, 2019)]
[Notices]
[Page 44640]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-18320]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Application: Clinical Supplies 
Management Holdings, Inc.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk importers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before September 25, 2019. 
Such persons may also file a written request for a hearing on the 
application on or before September 25, 2019.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
requests for a hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on June 5, 2019, Clinical Supplies Management Holdings, 
Inc., 342 42nd Street South, Fargo, North Dakota 58103 applied to be 
registered as an importer of the following basic classes of controlled 
substances:

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Marihuana..............................     7360  I
Tetrahydrocannabinols..................     7370  I
------------------------------------------------------------------------

    The company plans to import listed controlled substances in their 
finished dosage form for use in clinical trials only. Drug codes 7350 
(marihuana extract) and 7360 (marihuana) will be used for the 
manufacture of cannabidiol only.

    Dated: August 9, 2019.
Neil D. Doherty,
Acting Assistant Administrator.
[FR Doc. 2019-18320 Filed 8-23-19; 8:45 am]
 BILLING CODE 4410-09-P